Global Pharmacovigilance Market Size, Share, Trends & Growth Analysis Report 2026-2034

Description

The Pharmacovigilance Market size is expected to reach USD 16.44 Billion in 2034 from USD 8.94 Billion (2025) growing at a CAGR of 7.01% during 2026-2034.

The global pharmacovigilance market is expanding rapidly as the pharmaceutical industry places greater emphasis on drug safety and monitoring. Pharmacovigilance involves the detection, assessment, and prevention of adverse effects related to pharmaceutical products. It plays a critical role in ensuring patient safety and maintaining regulatory compliance throughout the lifecycle of a drug.

Several factors are driving the growth of the pharmacovigilance market. The increasing number of clinical trials and newly approved drugs is creating a greater need for post-marketing surveillance and safety monitoring. Regulatory authorities are also implementing strict safety guidelines that require pharmaceutical companies to monitor adverse drug reactions carefully. Additionally, the growing complexity of modern drug therapies is increasing the importance of advanced pharmacovigilance systems.

The future outlook for the pharmacovigilance market is highly promising as healthcare systems continue to prioritize patient safety. Advances in data analytics, artificial intelligence, and digital health technologies are improving the efficiency of safety monitoring processes. As pharmaceutical innovation continues to expand globally, pharmacovigilance will remain a crucial component of drug development and healthcare regulation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Life Cycle

Pre-clinical
Phase I
Phase II
Phase III
Phase IV

By Service Provider

In-house
Contract Outsourcing

By Type

Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining

By End Use

Pharmaceuticals
Biotechnology Companies
Medical Device Manufacturers
Others

By Therapeutic Area

Oncology
Neurology
Cardiology
Respiratory Systems
Others

By Process Flow

Case Data Management
Medical Reviewing & Reporting
Signal Detection
Risk Management System

COMPANIES PROFILED

Accenture, IQVIA Inc, Cognizant, Clinquest Group BV Linical Americas, IBM, Laboratory Corporation of America Holdings, ArisGlobal, Capgemini, ITClinical, ICON plc, TAKE Solutions Limited, Parexel International MA Corporation, Wipro, United BioSource LLC, BioClinica Inc Clario, ClinChoice formerly FMD KL
We can customise the report as per your requirements.

Product Code: VMR11212767

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL PHARMACOVIGILANCE MARKET: BY PRODUCT LIFE CYCLE 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Product Life Cycle
4.2. Pre-clinical Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Phase I Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Phase II Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.5. Phase III Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.6. Phase IV Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHARMACOVIGILANCE MARKET: BY SERVICE PROVIDER 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Service Provider
5.2. In-house Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Contract Outsourcing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHARMACOVIGILANCE MARKET: BY TYPE 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Type
6.2. Spontaneous Reporting Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Intensified ADR Reporting Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Targeted Spontaneous Reporting Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Cohort Event Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.6. EHR Mining Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHARMACOVIGILANCE MARKET: BY END USE 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast End Use
7.2. Pharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Medical Device Manufacturers Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PHARMACOVIGILANCE MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

8.1. Market Analysis, Insights and Forecast Therapeutic Area
8.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.3. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.4. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.5. Respiratory Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PHARMACOVIGILANCE MARKET: BY PROCESS FLOW 2022-2034 (USD MN)

9.1. Market Analysis, Insights and Forecast Process Flow
9.2. Case Data Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
9.3. Medical Reviewing & Reporting Estimates and Forecasts By Regions 2022-2034 (USD MN)
9.4. Signal Detection Estimates and Forecasts By Regions 2022-2034 (USD MN)
9.5. Risk Management System Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL PHARMACOVIGILANCE MARKET: BY REGION 2022-2034(USD MN)

10.1. Regional Outlook
10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 10.2.1 By Product Life Cycle
- 10.2.2 By Service Provider
- 10.2.3 By Type
- 10.2.4 By End Use
- 10.2.5 By Therapeutic Area
- 10.2.6 By Process Flow
- 10.2.7 United States
- 10.2.8 Canada
- 10.2.9 Mexico
10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 10.3.1 By Product Life Cycle
- 10.3.2 By Service Provider
- 10.3.3 By Type
- 10.3.4 By End Use
- 10.3.5 By Therapeutic Area
- 10.3.6 By Process Flow
- 10.3.7 United Kingdom
- 10.3.8 France
- 10.3.9 Germany
- 10.3.10 Italy
- 10.3.11 Russia
- 10.3.12 Rest Of Europe
10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 10.4.1 By Product Life Cycle
- 10.4.2 By Service Provider
- 10.4.3 By Type
- 10.4.4 By End Use
- 10.4.5 By Therapeutic Area
- 10.4.6 By Process Flow
- 10.4.7 India
- 10.4.8 Japan
- 10.4.9 South Korea
- 10.4.10 Australia
- 10.4.11 South East Asia
- 10.4.12 Rest Of Asia Pacific
10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 10.5.1 By Product Life Cycle
- 10.5.2 By Service Provider
- 10.5.3 By Type
- 10.5.4 By End Use
- 10.5.5 By Therapeutic Area
- 10.5.6 By Process Flow
- 10.5.7 Brazil
- 10.5.8 Argentina
- 10.5.9 Peru
- 10.5.10 Chile
- 10.5.11 South East Asia
- 10.5.12 Rest of Latin America
10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 10.6.1 By Product Life Cycle
- 10.6.2 By Service Provider
- 10.6.3 By Type
- 10.6.4 By End Use
- 10.6.5 By Therapeutic Area
- 10.6.6 By Process Flow
- 10.6.7 Saudi Arabia
- 10.6.8 UAE
- 10.6.9 Israel
- 10.6.10 South Africa
- 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

11.1. Recent Developments
11.2. Company Categorization
11.3. Supply Chain & Channel Partners (based on availability)
11.4. Market Share & Positioning Analysis (based on availability)
11.5. Vendor Landscape (based on availability)
11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL PHARMACOVIGILANCE INDUSTRY

12.1. Top Companies Market Share Analysis
12.2. Company Profiles
- 12.2.1 Accenture
- 12.2.2 IQVIA Inc
- 12.2.3 Cognizant
- 12.2.4 Clinquest Group B.V. (Linical Americas)
- 12.2.5 IBM
- 12.2.6 Laboratory Corporation Of America Holdings
- 12.2.7 ArisGlobal
- 12.2.8 Capgemini
- 12.2.9 ITClinical
- 12.2.10 ICON Plc
- 12.2.11 TAKE Solutions Limited
- 12.2.12 Parexel International (MA) Corporation
- 12.2.13 Wipro
- 12.2.14 United BioSource LLC
- 12.2.15 BioClinica Inc. (Clario)
- 12.2.16 ClinChoice (Formerly FMD K&L)